/Investor DB

New Enterprise Associates (NEA)

Venture capitalActively deploying

Menlo Park · Seed–Growth · 81 people tracked

Also known as NEA · Nea Management Company, Llc · New Enterprise Associates · New Enterprise Associates 17

Find your way into New Enterprise Associates (NEA)

Sign up to see every warm intro you have to New Enterprise Associates (NEA)

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the New Enterprise Associates (NEA) team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

NEA views venture investment as an enduring commitment to the people executing on innovative ideas rather than a transactional financial engagement. The firm partners with founders to support the realization of transformative concepts.

Source: firm website, verified Oct 13, 2026.

Stage
Seed–Growth
Check
$200K – $40M
HQ
Menlo Park, CA, US
Leads rounds
Leads
Instruments
Equity
Founded
1977
Last 12 months
55 investments
AUM
$35.6B
Tracked investments
1231
Unicorns
62
IPOs
74
Acquisitions
96

Team · 81 people

from the firm's website & curated & public directories
Gregory Dracon· General Partner
John Brooks· General Partner
Joshua Makower· General Partner

Joshua Makower is a physician, inventor, and venture investor focused on medical devices and consumer health technologies. He founded and serves as Executive Chairman of ExploraMed, a medical device incubator that has created ten companies since 1995, several of which have been acquired by larger medical companies including NeoTract (to Teleflex), Acclarent (to J&J), EndoMatrix (to C.R. Bard), and TransVascular (to Medtronic). He has been a General Partner at New Enterprise Associates since 2015, where he focuses on the firm's healthcare investments and has worked with NEA since 1995. Makower co-founded Stanford's Biodesign program with Paul Yock and serves as its director and as a professor at Stanford's schools of medicine and engineering, helping develop the Biodesign Process curriculum. He holds more than 300 patents and patent applications across multiple medical fields. He is a member of the National Academy of Engineering and a fellow of the National Academy of Inventors and the American Institute for Medical and Biological Engineering. Before his incubator work he founded and ran Pfizer's Strategic Innovation Group.

Krishna S. Kolluri· General Partner
Liam Donohue· General Partnerin𝕏

Liam Donohue co-founded one of the earliest dedicated edtech funds, opened Booz Allen Hamilton’s Budapest office post–Berlin Wall, and co-runs a firm with spouse So‑June Min championing .406 batting‑average discipline.

Liza K. Landsman Gold· General Partner
M. James Barrett· General Partner

M. James Barrett is a venture capital investor who joined New Enterprise Associates (NEA) as a General Partner in 2001, where he focuses on biotechnology and collaborates with the firm's healthcare investment group on medical devices and specialty pharmaceutical companies. Before entering venture capital, he founded and led Sensors for Medicine and Science, serving as its Chairman and CEO from 1997 to 2001. Earlier in his career he ran several NEA-funded companies, including Genetic Therapy, Inc. as Chairman and CEO, Life Technologies as President and CEO, and Bethesda Research Labs as President and CEO. He also worked in various divisions of SmithKline prior to 1982. He has held board roles at companies including GlycoMimetics, Clovis Oncology, PhaseBio Pharmaceuticals, Psyadon Pharmaceuticals, Roka Bioscience, and Senseonics. He holds a Ph.D. in biochemistry, an M.B.A., and a B.S. in chemistry.

Payal Divakaran· General Partner
Ravi Viswanathan· General Partnerin𝕏

Ravi founded NewView Capital in 2018, raising $1.35B and structuring a portfolio acquisition of 31 companies from NEA. He was previously a General Partner at NEA focused on enterprise software and fintech and co-led its growth equity effort, and earlier worked at Goldman Sachs, McKinsey, and Raychem.

Ryan D. Drant· General Partner
Harry Weller· General Partner

Harry Weller led New Enterprise Associates' East Coast technology practice and backed cloud and infrastructure companies including MongoDB, appearing on the Midas List nine times before his death in 2016.

Suzanne King· Special Partner, LP Relationsin

Suzanne King is a Kauffman Fellow, a member of Class 1 of the two-year venture capital leadership program run by Kauffman Fellows. The program's member directory lists them at New Enterprise Associates in United States.

Alex Sharata· Partnerin𝕏

Alex Sharata is an investor at New Enterprise Associates who joined the firm in 2020 to lead its growth-stage investing practice across enterprise, fintech, and consumer sectors. Previously, he was an investor at Vista Equity Partners focused on majority investments in enterprise software and co-founded Fractal, a mobile app security company that was acquired in 2017. He holds a B.S. in computer science and economics from Johns Hopkins University.

Arjun Jain· Partnerin

Arjun Jain is a Partner on the technology team at NEA, which he joined in 2021, focusing on consumer and enterprise investments as well as portfolio management. Before NEA, he was a merchant banker at The Raine Group in New York, working on M&A and growth equity deals across technology, media, and entertainment, and earlier worked in Sales & Trading at J.P. Morgan. He holds a BA in economics from Princeton University.

Lila Tretikov· Partner, Head of AI Strategyin𝕏

Lila Tretikov is a Partner and Head of AI Strategy at NEA, investing across multiple stages, sectors, and geographies. Previously, she served as Deputy CTO at Microsoft leading AI transformation initiatives, and held executive roles including SVP at Engie and CEO of Terrawatt, where she oversaw the company's pivot toward new energy sources. She also served as CEO of Wikimedia Foundation, where she established the Wikipedia Endowment and developed the organization's AI strategy.

Luke Pappas· Partnerin𝕏

Luke Pappas is a Partner on NEA's Technology team focused on consumer and enterprise investing. Previously, he worked in Technology Investment Banking at Morgan Stanley. He holds dual BS degrees in computer science and management science & engineering from Stanford University.

Aaron Jacobson· Partnerin𝕏

Aaron Jacobson joined NEA in 2011 and works with founders in AI, cybersecurity, developer tools, and robotics. Before NEA, he spent two years in M&A advisory at Qatalyst Partners in San Francisco. He graduated summa cum laude from the Jerome Fisher Program in Management & Technology at the University of Pennsylvania with dual B.S. degrees in economics and electrical engineering and a minor in math.

Carmen Chang· Special Partnerin

Carmen Chang joined NEA in 2012 as a Special Partner and previously led the firm's Asia practice, building its presence in China and other emerging Asian markets while also working on US and European investments. Before NEA, she was a partner at a Silicon Valley law firm, specializing in corporate and securities law and leading its China practice. She holds a JD from Stanford Law School.

Paul Walker· Partner and Co-Head of Healthcare, NEA

Paul Walker leverages 25+ years in public biotech markets, biochemistry training and a CFA, focusing on later-stage/public/crossover biotech as a contrarian, patient multi-year partner to public companies recovering from setbacks.

Scott Gottlieb· Partnerin𝕏

Scott Gottlieb is a physician and policy expert who joined NEA's healthcare investment team as a Special Partner in 2019, having previously been a Venture Partner at the firm from 2007 to 2017. Between those roles he served as the 23rd Commissioner of the U.S. Food and Drug Administration (2017–2019), and earlier held positions as FDA Deputy Commissioner and Senior Adviser at the Centers for Medicare and Medicaid Services. He was a practicing hospitalist and Clinical Assistant Professor at NYU School of Medicine, is a graduate of Mount Sinai School of Medicine and Wesleyan University, and at NEA focuses on healthcare investing with an emphasis on biopharma and healthcare services.

Melissa Taunton· Partnerin

Partner at NEA.

Pete Sonsini· General Partner, NEAin𝕏

Forbes Midas List investor Pete Sonsini, son of Larry Sonsini, co-founded a venture fund paired with a nonprofit institute that funds open research (Slingshots, Moonshots) and backs teams.

J.C. Lopez· Principalin
James Buxton· Principalin

James Buxton is a Principal on NEA's Healthcare team focused on life sciences investing. He trained as a cardiothoracic surgeon before transitioning to venture capital, having previously worked at SR One Capital Management, Morgan Stanley, and New Rhein Healthcare Investors. He holds a BSc and MD from University College London and an MBA from The Wharton School.

Lulu Xu· Principalin
Michael Li· Principalin
Brooke Seawell· Venture Partnerin

Brooke joined NEA in 2005 as a Venture Partner with expertise in software, systems, and internet investments. He brings over 40 years of experience in technology finance and operations, with a 25-year background as an operating executive at technology companies, having taken three public and sold one to Sun Microsystems. At NEA, he leverages his founding and operating experience to mentor portfolio company operators and serves on the boards of NVIDIA, Tenable, and GoodLeap.

Greg Papadopoulos· Venture Partnerin

Greg joined NEA as Venture Partner in 2010 and focuses on early-stage systems, software, and deep/hard-tech companies. Previously he served as EVP and CTO at Sun Microsystems and was an Associate Professor of EECS at MIT. Earlier in his career, he held engineering positions at HP and Honeywell, and co-founded companies in video conferencing, AI accelerators, portable PCs, and computational fluid dynamics.

Hilarie Koplow-McAdams· Venture Partnerin𝕏

Hilarie is a Venture Partner at NEA focused on enterprise software and services. She spent three decades in operating and board roles at growth-stage software companies, including serving as President at New Relic and President of Worldwide Sales at Salesforce. She began her career at Oracle and Intuit, and holds a master's degree in public policy from the University of Chicago and a bachelor's degree from Mills College.

Jeff Immelt· Venture Partnerin𝕏

Jeff Immelt is a Venture Partner at NEA who previously served as Chairman and CEO of GE for 16 years, where he led strategic and organizational transformation. He brings experience in business leadership across diverse industries and focuses on healthcare, industrial automation, clean tech, and IoT investments. Immelt holds a BA in applied mathematics from Dartmouth College and an MBA from Harvard University.

Kavita Patel· Venture Advisor, Healthcare Teamin𝕏

Kavita Patel is a Venture Advisor on NEA's Healthcare team, joining the firm in 2017. She holds an MD from the University of Texas Health Science Center and an MS in health services research from UCLA, and has experience as both a practicing physician and researcher. Previously she served in the Obama Administration as Director of Policy for the Office of Intergovernmental Affairs and Public Engagement, and currently serves as a Nonresident Fellow at The Brookings Institution.

Mark Hawkins· Venture Partnerin𝕏

Mark Hawkins is a Venture Partner at NEA focused on technology investments, joining the firm in 2023. He previously served as President and CFO of Salesforce and held executive financial roles at Autodesk, Logitech, Dell, and HP. He holds a BA in operations management from Michigan State University, an MBA from the University of Colorado, and completed the Advanced Management Program at Harvard Business School.

Michele Park· Venture Partnerin

Michele Park is an investor at New Enterprise Associates focused on the biopharma sector. She previously held investor roles at Clarus Ventures (now Blackstone Life Sciences) and worked as a biotechnology research analyst at Credit Suisse and Piper Jaffray. She holds a PhD in molecular biology from Weill Cornell Graduate School of Medical Sciences, where she completed her dissertation at Memorial Sloan Kettering Cancer Center, and a BA in molecular biology from Princeton.

Scott Sandell· Executive Chairman & Chief Investment Officerin𝕏

Scott Sandell joined NEA in 1996, became managing general partner in 2016, and now serves as the firm's executive chairman and chief investment officer. His investments span Salesforce, Workday, Tableau and Robinhood, with Cloudflare — where he is lead independent director — standing out as his defining deal. A Dartmouth and Stanford GSB graduate, he is also a public advocate for employing people with disabilities, drawing on his own experience with dyslexia.

Anna Golynskaya· Partner, Head of Capital Formation and LP Relations
Ashley Mitchell· Director, Marketing
Brad Thawley· Partner, LP Relations
Darcy Casarella· VP of Talent
Elie de Fressenel· Associatein
Emily Baine· VP of Talent
Erica Sunkin· Director, Communications
Grace Carlson· Senior Associate, LP Relations
Jennifer Ball· Director, LP Relations
Kate Barrett· Partner, Head of Communications & Marketing
Michelle Wherley· Director, LP Operations
Nick Kline· Partner, LP Relations
Ron Kosar· Chief Financial Officer, Partnership Finance
Sachin Shah· Associate, Capital Formation & LP Relations
Sam Cohen· Chief Financial Officer, Corporate Finance and Tax
Shanna Hendriks· Director, Business Development
Stephanie Brecher· Chief Legal Officer
Tracy Howe· Director, LP Relations, ESG & Events
Alexa Grabelle· Associatein
Andrew Schoen· Partnerin𝕏

Andrew Schoen is a Partner on NEA's Technology Investing Team, where he has worked since 2014. Before joining NEA, he was part of Blackstone's M&A team and co-founded Flicstart, which was acquired. He holds a master's degree as a Schwarzman Scholar and a bachelor's degree in economics and engineering from Cornell University.

Ayush Goradia· Principalin
Claudia Fan Munce· Venture Advisor
Danielle Ezratty· Senior Associatein

Danielle Ezratty joined NEA in 2023 to focus on digital health investments. She previously worked at Clayton, Dubilier & Rice on its healthcare team conducting growth and buyout investing in healthcare services. Before that, she spent time at Morgan Stanley's Investment Banking division advising on M&A transactions in natural resources and global industrials. She holds a BS in economics with a finance concentration from Duke University, where she graduated Phi Beta Kappa, summa cum laude.

Danielle Lay· Partnerin𝕏

Danielle Lay is a Partner on NEA's Technology Investing Team, investing from seed to growth in generational companies focused on AI applications and physical AI. Before joining NEA in 2017, she worked as an investment banker at Goldman Sachs. She holds a BA in Economics, Business Institutions and Chinese from Northwestern University.

Forest Baskett· Special Partnerin

Forest Baskett, a systems‑level technologist, co‑designed the Sun workstation with Andy Bechtolsheim, built a RISC at DEC that beat the VAX, served as SGI CTO, and retains founder ties.

Hui Cheng· Principalin

Hui Cheng is a Principal at New Enterprise Associates focusing on digital health investing across all stages. She previously served as Vice President at Town Hall Ventures, where she led early to mid-stage healthcare services investments. She began her career at Bain & Company in the healthcare and private equity practice and held business operations roles at an early-stage software startup. She holds a BA in Government from Dartmouth College.

Hunter Worland· Principalin
Kevin Deng· Associatein

Kevin joined NEA in 2024 as an Associate on the Healthcare Investing Team, investing across all stages. He previously worked in the Healthcare Investment Banking group at Goldman Sachs, focusing on M&A and capital markets advisory for biopharma and healthcare services companies. He holds a BA in Computational Biology and a BS in Economics from the University of Pennsylvania, where he graduated summa cum laude.

Madison Faulkner· Venture Advisorin
Mason Murray· Principalin

Mason Murray is a Principal on NEA's Technology team, which he joined in 2022, where he invests in consumer and enterprise companies. Before NEA, he worked on M&A, equity, and debt transactions in Bank of America's Technology, Media & Telecom investment banking group. He holds BA degrees in business management and art history from Columbia University.

Mustafa Neemuchwala· Partnerin

Mustafa is a Partner on NEA's Technology Investing Team, focusing on investments from seed to late-stage growth in AI, cybersecurity, infrastructure, defense, and frontier technologies. Before joining NEA in 2021, he advised on approximately $58 billion in technology M&A transactions at Qatalyst Partners, with expertise spanning frontier tech, infrastructure, application software, cybersecurity, fintech, and consumer internet. He holds degrees from the University of Texas at Austin in finance, liberal arts, computer science, and mathematics.

Neehaar Gandhi· Associatein

Neehaar Gandhi is an investor at NEA focused on growth-stage investments in the technology sector. He previously worked at Fifth Wall and The Raine Group, supporting companies across physical world and media/tech/telecom ecosystems respectively. He graduated from Yale University with dual degrees in Statistics & Data Science and Environmental Studies.

Patrick Kerins· Special Partnerin

Patrick Kerins is a Special Partner at New Enterprise Associates focused on enterprise software, digital media, and growth-stage companies. He holds an MBA from Harvard Business School and has experience in venture capital investing.

Perry Wallack· Associatein
Philip Chopin· Managing Director, Head of Europein𝕏

Philip Chopin is Managing Director and Head of Europe at NEA, which he joined in 2022 to open the firm's first European office in London. Before NEA, he was a Partner at 83North and earlier worked as a Project Leader at BCG. He holds an MBA from Kellogg and an MSc from Grenoble Ecole de Management.

Ryan Psik· Associatein
Thomas Joshi· Associatein
Tiffany Le· Principalin𝕏

Tiffany Le is a Principal at New Enterprise Associates (NEA), a venture capital firm.

Tiffany Luck· Partnerin𝕏

Tiffany Luck is a Partner at New Enterprise Associates focused on early-stage AI, APIs, and B2B SaaS investments. Previously, she was a Partner at GGV Capital where she led investments in companies including Pinwheel, Mindee, Stream, Electric.ai, Fairmarkit, Workboard, and Vic.ai. Her background includes roles in marketing and business development at Forbes, Lot18, and Amazon, as well as technology investment banking at Morgan Stanley advising clients such as Github, Netflix, and Zoom.

Ali Behbahani· Partner, co-head of healthcare teamin

Ali Behbahani is a Partner at NEA, which he joined in 2007, and co-heads the firm's healthcare team with a focus on biopharmaceuticals and medical devices. He previously worked at The Medicines Company, Morgan Stanley, and Lehman Brothers, and conducted research at the National Institutes of Health and Duke University. He holds an MD from the University of Pennsylvania School of Medicine, an MBA from The Wharton School, and undergraduate degrees in biomedical engineering, electrical engineering, and chemistry from Duke University.

Blake Wu· Partnerin

Blake Wu joined NEA in 2014 and invests in digital health, including healthcare services and healthcare IT, as well as biopharmaceuticals. He previously worked in the private equity group at Ares Management focused on healthcare, and earlier held roles in investment banking at Moelis & Company and equity research at Barclays Capital. He holds a BS in economics from The Wharton School at the University of Pennsylvania.

Ed Mathers· Partnerin

Ed Mathers is a Partner on NEA's healthcare team, where he has worked since 2008, focusing on biotechnology and specialty pharmaceuticals investments. Before NEA, he was EVP of Corporate Development and Venture at MedImmune, contributing to its 2007 sale to AstraZeneca, and previously held roles at Inhale Therapeutic Systems and Glaxo Wellcome (now GSK). His investment interests include gene therapy, nonviral gene therapy, RNA editing, and immunology and inflammation.

Mohamad Makhzoumi· Co-CEOin

Mohamad Makhzoumi joined NEA in 2000 and serves as Co-CEO, previously Co-President and Managing General Partner of Healthcare, leading the firm's global healthcare investing across digital health and life sciences from early venture to late-stage growth. He is also a board member of the Lucile Packard Foundation for Children's Health at Stanford.

Rick Yang· Partner, Head of Technologyin𝕏

Rick Yang grew up in one firm over nearly two decades, focusing on consumer behavior and financial infrastructure and championing consumer-grade experiences in opaque markets like healthcare.

Tony Florence· Co-CEOin𝕏

Tony Florence is a hands-on, long-term board partner and trusted mentor who uses his former head-of-tech experience and Co-CEO leadership to support brand-driven, digital-commerce breakouts like Casper and Goop.

Peter Barris· Chairman Emeritus New Enterprise Associatesin

Advisor to the firm; Chairman Emeritus of New Enterprise Associates.

Ashely Jepson

Founder mafia

26 people who came through New Enterprise Associates (NEA) went on to found or lead other companies.

+ 14 more

What they invest in

from 821 of 1231 portfolio companies

AI & Machine Learning ×295SaaS ×224Enterprise Software ×221Healthtech ×192Biotech ×153Data & Infrastructure ×93Consumer ×91Developer Tools ×84

HQs:United States×617United Kingdom×15China×10India×10Canada×8Japan×7

Who they back

founder profiles across 459 portfolio companies
32%
solo founders
145 of 459 mapped founding teams
39%
repeat founders
of 521 founders with career history
~3 yrs
old at investment
median across 251 dated deals

Founding team size:solo founder×1452 founders×1363 founders×924+ founders×86

Where their founders studiedfrom 492 founders with education data

Stanford University ×37University of California, Berkeley ×30Massachusetts Institute of Technology ×24Stanford University Graduate School of Business ×18Harvard Business School ×16Cornell ×15Duke University ×13University of Oxford ×13

What their founders studiedfrom 464 founders with field-of-study data

Computer Science ×178Engineering ×115Business & Management ×63Economics ×38Finance & Accounting ×28Mathematics & Statistics ×26Life Sciences ×23Physics ×22

Where their founders worked beforefrom 521 founders with career history

Google ×46Microsoft ×29Stanford University ×25IBM ×10Goldman Sachs ×8Workday ×8McKinsey & Company ×7Meta ×7

Accelerator rootsportfolio companies that came through a program

Y Combinator ×25Techstars ×10500 Global ×3

91 founders hold a PhD · 74 hold an MBA (of 511 with degree data) · backed the same founder in 2+ companies: 8 founders

Investments · showing 1200 of 1231

founders shown can be your intro path

By year:2026 · 452025 · 522024 · 262023 · 322022 · 632021 · 392020 · 242019 · 392018 · 402017 · 362016 · 302015 · 38540 dated

Monte Rosa Therapeuticsmonterosatx.comin𝕏NASDAQ: GLUESep 2020✓ verified

Monte Rosa develops molecular glue degrader (MGD) therapeutics using MGD chemistry, artificial intelligence, structural biology, and proteomics to target previously undruggable or inadequately drugged disease targets.

AI & Machine LearningBiotechDeep TechHealthtechBoston, US

Markus Warmuth(Chief Executive Officer)inSharon Townson(Ph.D., Chief Scientific Officer)inJohn Castle(Ph.D., Chief Data and Information Officer)inFilip Janku(M.D., Ph.D., Chief Medical Officer)inPhil Nickson(Ph.D., J.D., Chief Business and Legal Officer)inMagnus Walter(DPhil, Chief Technology Officer)in

Board seatAli Behbahani· per SEC Form D

Co-investorsAisling CapitalHBM PartnersVersant VenturesAmzak HealthAvoro Capital AdvisorsGV (Google Ventures)+4 more

BuzzFeedbuzzfeed.com𝕏NASDAQ: BZFDSeries C · Feb 2015 · $16M

BuzzFeed is a digital media company that produces entertainment, news, and content across pop culture, food, and commerce for online audiences.

ConsumerCreator EconomyMedia & EntertainmentNew York, US

Jonah Peretti(Founder)inJohn Johnson III(Director)Mark Frackt(Executive Officer)Greg Coleman(Executive Officer, Director)Allison Lucas(Executive Officer)JON STEINBERG(President and Chief Operating Officer)in

Board seatPatrick Kerins· per SEC Form D

Co-investorsAndreessen HorowitzGeneral AtlanticLerer HippeauRRE VenturesVelvet Sea VenturesHearst Ventures+3 more

Courseracoursera.orgin𝕏NYSE: COURJul 2020

Coursera is an online learning platform offering courses, certificates, and career programs from universities and companies such as Google.

EdTechEnterprise SoftwareFuture of WorkMarketplacesSaaSMountain View, US

Daphne Koller(Founder)inAndrew Ng(Co-founder)inRichard Levin(Chief Executive Officer)Andrew Y. Ng(Founder)in

BoardDan Avida(Director)

Board seatScott Sandell· per SEC Form D

Co-investors1802 VenturesAlign VenturesAllied Venture PartnersAlpha PartnersBVP InvestorsFelicis Ventures+16 more

CVRxcvrx.comin𝕏NASDAQ: CVRXMay 2016

CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.

BiotechHealthtechMedical DevicesAustin, US

Craig Palmer(Executive Officer)inNadim Yared(Executive Officer, Director)inDean Bruhn-Ding(Executive Officer)inJohn Brintnall(Executive Officer)inLiz Galle(Executive Officer)Kevin Hykes(President, Chief Executive Officer & Director)in

Board seatAli Behbahani· per SEC Form D

Co-investorsABS VenturesTreo Ventures, LlcWindham Capital PartnersYsios CapitalAction Potential Venture Capital Ltd.Hatteras Venture Partners+1 more

Mirum Pharmaceuticalsmirumpharma.comin𝕏NASDAQ: MIRMNov 2018

Mirum Pharmaceuticals is a biopharmaceutical company that develops and delivers therapies for people living with rare diseases.

BiotechHealthtechSan Diego, US

Chris Peetz(Co-founder & Chief Executive Officer)inEric Bjerkholt(Executive Officer)inPeter Radovich(Executive Officer)in

BoardPatrick Heron(Director)inMichael Grey(Director)Timothy Walbert(Director)

Board seatEdward T. MathersEd Mathers· per SEC Form D

Co-investorsChiesi VenturesFrazier Life SciencesLongitude CapitalMESA VERDE VENTURE PARTNERSPappas CapitalRiverVest Venture Partners+4 more

NextNav HoldingsNASDAQ: NNSep 2016SEC filingmedium confidence

NextNav Holdings develops ground-based positioning, navigation, and timing systems designed to complement and back up GPS using low-band spectrum assets, serving wireless carriers, government agencies, and public safety applications including enhanced 911 services.

Mclean, US

Ganesh Pattabiraman(Executive Officer, Director)Eric Swank(Chief Financial Officer)Gary Parsons(Executive Officer, Director)Mariam Sorond(President and Chief Executive Officer and Chair of the Board of Directors)

BoardBandel Carano(Director)inMatt Skaruppa(Director)

Board seatPeter Barris· per SEC Form D · $35M raise · filed Sep 2016

Co-investorsOak Investment Partners

Nkarta, Inc.nkartatx.cominNASDAQ: NKTXAug 2019

Nkarta is a biotech company developing allogeneic CAR NK cell therapies for autoimmune diseases, aiming to offer safer and more accessible alternatives to autologous CAR-T treatments.

BiotechHealthtechSouth San Francisco, US

Paul Hastings(Executive Officer, Director)inPaul H.inMatthew Plunkett(Executive Officer)in

BoardMichael Dybbs(Director)Jill Carroll(Director)inTiba Aynechi(Director)in

Board seatAli Behbahani· per SEC Form D

Co-investorsRA CapitalSamsara BioCapitalSR One Capital ManagementAmgen VenturesLogosNorwest Venture Partners+1 more

Onkure Therapeutics Inconkuretherapeutics.comin𝕏NASDAQ: OKUROct 2024

OnKure Therapeutics is a clinical-stage biopharmaceutical company developing PI3Kα pan-mutant selective inhibitor medicines for the treatment of breast cancer and vascular anomalies.

BiotechDigital HealthHealthtechMedical DevicesBoulder, US

Jason Leverone(Executive Officer)inSamuel Agresta(Executive Officer)inDylan Hartley(Executive Officer)inWendy Johnson(Executive Officer)Nicholas A. Saccomano(President and Chief Executive Officer and Director)

BoardIsaac Manke(Director)in

Board seatEdward T. Mathers· per SEC Form D

Co-investorsAccess BiotechnologyBoulder VenturesRiverVest Venture PartnersAbingworthACORN BIOVENTURESNovo Holdings

Robinhoodrobinhood.comin𝕏NASDAQ: HOODOct 2020

Robinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets.

FintechMenlo Park, US

Vlad Tenev(Founder)inBaiju Bhatt(Founder)inJason Warnick(Chief Financial Officer)inGretchen Howard(Executive Officer)inVladimir Tenev(Founder)

Board seatScott Sandell· per SEC Form D

Co-investors1/1 CapitalACME CapitalAlgerAliya Capital PartnersAmplo VenturesAndreessen Horowitz+66 more

Senti Biosciencessentibio.comin𝕏NASDAQ: SNTIFeb 2018

Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells.

BiotechDeep TechMedical DevicesSouth San Francisco, US

Tim Lu(Co-Founder and Chief Executive Officer)inPhilip Lee(Executive Officer)inKanya Rajangam(President, Head of Research & Development and Chief Medical Officer)inYvonne Li(Executive Officer)inJames Collins(Director)Timothy Lu(Founder)

Board seatEd Mathers· per SEC Form D

Co-investorsEvolution VC PartnersFlucas VenturesGaingelsGreen Sands EquityLifeforce CapitalLifeSci Venture Partners+13 more

Sprout Social, Inc.sproutsocial.comin𝕏NASDAQ: SPTDec 2018 · $40.5M

Sprout Social offers a social media management platform with AI, automation, integrations and analytics tools for marketing teams.

AI & Machine LearningMarketing TechSaaSSocialChicago, US

Aaron Rankin(Founder)inJustyn Howard(Founder)inPeter Soung(Founder)inGil Lara(Founder)

BoardEric Lefkofksy(Director)

Board seatPeter Barris· per SEC Form D

Co-investorsLightbankGoldman Sachs

Spyglass Pharmaspyglasspharma.cominNASDAQ: SGPMay 2025

SpyGlass Pharma develops a sustained drug delivery platform for treating chronic ophthalmic diseases such as glaucoma, integrating drugs, procedures, and devices for long-term disease control and vision preservation.

BiotechHealthtechMedical DevicesAliso Viejo, US

Glenn Sussman(Co-founder)inMalik Y. Kahook(Co-founder)inPatrick Mooney(CEO)

BoardJake Merrill(Director)Geoff Pardo(Director)Bilal Khan(Director)

Board seatAli Behbahani· per SEC Form D

Co-investorsRA CapitalSamsara BioCapitalSands Capital VenturesVensana Capital

Synlogicsynlogictx.comin𝕏OTC: SYBXFeb 2016

Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases.

BiotechDeep TechMedical DevicesCambridge, US

Bharatt Chowrira(Executive Officer)inMichael Sheahan(Executive Officer)Jose Carlos Gutierrez-Ramos(Executive Officer, Director)inPaul Miller(Executive Officer)inAoife Brennan(Executive Officer)inTodd Shegog(Executive Officer)in

Board seatEd Mathers· per SEC Form D

Co-investorsAtlas VentureCLI VenturesNSG VenturesPfizer Venture InvestmentsSofinnova VenturesSolasta Ventures+1 more

Tempustempus.comNASDAQ: TEMOct 2022

Tempus AI develops artificial intelligence-powered diagnostic tests that integrate genomic, clinical, and imaging data to guide personalized treatment decisions in oncology and other disease areas.

Chicago, US

Eric Lefkofsky(Founder)inErik Phelps(Executive Officer)Ryan Fukushima(Executive Officer)in

BoardBrad Keywell(Director)

Board seatScott GottliebPeter Barris· per SEC Form D

Co-investorsCaesar VenturesCompoundFPVKhosla VenturesLightbankLingotto+4 more

Twiliotwilio.comin𝕏NYSE: TWLOJul 2021SEC filingmedium confidence

Twilio provides a cloud-based communications platform that enables businesses to integrate voice, messaging, and video into applications using APIs.

Cloud ComputingDeveloper ToolsEnterprise SoftwareSan Francisco, US

Jeff Lawson(Founder)inEvan Cooke(Founder)John Wolthuis(Founder)inLee Kirkpatrick(Chief Financial Officer)inRoy Ng(Executive Officer)inKaryn Smith(Executive Officer)in

Board seatJeff Immelt· per SEC Form D · $378.2M raise · filed Jul 2021

Co-investors500 GlobalBessemer Venture PartnersCraft VenturesDraper AssociatesFounders Circle CapitalFounders Fund+21 more

Actelis Networksactelis.comin𝕏OTC: ASNSFeb 2005 · $23M

Actelis provides networking technology that it calls NetScience, using hybrid fiber-copper connections to deliver high-bandwidth, encrypted monitoring and control over existing and new networks.

CybersecurityEnterprise SoftwareHardwareIoTFremont, US

Tuvia Barlev(Chief Executive Officer, Chairman of the Board, and Secretary; founded the company in 1998)inEyal Aharon(Executive Officer)inHemi Kabir(Executive Officer)inYaron Altit(Executive Officer)inBret Harrison(Executive Officer)inElad Domanovitz(Executive Officer)in

Co-investorsSaints CapitalWestern Technology InvestmentAdams Street PartnersWalden International

Adaptimmuneadaptimmune.comin𝕏OTC: ADAPYSep 2014

Adaptimmune Therapeutics is a biotechnology company, though the specific focus of their therapeutic work is not detailed on this investors and media page.

BiotechHealthtechMedical DevicesAbingdon, Oxfordshire, US

James Noble(Chief Executive Officer)Adrian Rawcliffe(Chief Executive Officer and Director)inGavin Wood(Chief Financial Officer)inWilliam Bertrand(Chief Operating Officer)inJohn Lunger(Chief Patient Supply Officer)inElliot Norry(Chief Medical Officer)in

Co-investorsAvoro Capital AdvisorsEight Roads VenturesF-Prime CapitalForesite CapitalRidgeback Capital

Addex Therapeuticsaddextherapeutics.comin𝕏NASDAQ: ADXN

Addex Therapeutics is a clinical-stage pharmaceutical company that develops orally available small molecule drugs known as allosteric modulators for neurological disorders.

BiotechHealthtechGeneva

Roger Mills(Executive Officer, Director)inMikhail Kalinichev(Executive Officer)inJean-Philippe Rocher(Executive Officer)inRobert Lutjens(Executive Officer)inTimothy Dyer(Executive Officer, Director)Vincent Lawton(Director)

Co-investorsSofinnova PartnersACORN BIOVENTURESSR One Capital Management

Akari Therapeuticsakaritx.comin𝕏NASDAQ: AKTX

Akari Therapeutics is an oncology biotechnology company developing antibody drug conjugates (ADCs) built on a proprietary PH1 spliceosome-modulating payload that disrupts RNA splicing in cancer cells.

BiotechDeep TechHealthtechTampa, US

Kameel Farag(Interim Chief Financial Officer)inAbizer Gaslightwala(President and Chief Executive Officer)inGur Roshwalb(Executive Officer, Director)inClive Richardson(Executive Officer, Director)inDov Elefant(Executive Officer)Ray Prudo(Director)

Amplitudeamplitude.comin𝕏NASDAQ: AMPLMay 2021

Amplitude provides an AI analytics platform that helps companies understand customer behavior and make data-driven product decisions.

Data & InfrastructureDeveloper ToolsEnterprise SoftwareMarketing TechSaaSSan Francisco, US

Spenser Skates(CEO)inCurtis Liu(CTO)inJeffrey Wang(Founder)inAndrew Casey(Chief Financial Officer)inNathaniel Crook(Chief Commercial Officer)inBilal Mahmood(Head of Product)in

Co-investorsBattery VenturesSequoia Capital91 VenturesArtisanal VenturesBoxGroupDCVC (Data Collective)+21 more

Black Diamond Therapeutics, Incblackdiamondtherapeutics.comNASDAQ: BDTX

Black Diamond Therapeutics develops small-molecule kinase inhibitors targeting families of oncogenic mutations across cancer types, including its lead candidate silevertinib for EGFR-mutant lung cancer and glioblastoma.

Elizabeth Buck(Chief Scientific Officer)inBrent Hatzis-Schoch(Chief Operating Officer and General Counsel)inSergey Yurasov(Chief Medical Officer)inMelanie Morrison(Chief Development Officer)

Co-investorsLAVLilly Asia VenturesNextech InvestNSG VenturesRA CapitalVersant Ventures+4 more

Bloom Energybloomenergy.comin𝕏NYSE: BE

Bloom Energy manufactures solid oxide fuel cell systems for onsite power generation at commercial, industrial, and data center facilities.

CleantechEnergyHardware

K.R. Sridhar(Founder, Chairman, and CEO)KR Sridhar, PhD(Founder, Chairman and Chief Executive Officer)K. R. Sridhar(Founder)KR Sridhar(Founder)

Co-investorsAlumni VenturesArtis VenturesATEL VenturesConstellation Technology VenturesDag VenturesEnerdigm Ventures+10 more

Boston Scientificbostonscientific.cominNYSE: BSXAcquired

Boston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.

HealthtechMedical Devices

John Abele(Founder)inPeter Nicholas(Founder)Lance BatesinJonathan R. Monson(Executive Vice President and Chief Financial Officer)Miriam O'Sullivan(Senior Vice President, Chief Human Resources Officer)inMichael F. Mahoney(Chairman of the Board, President and Chief Executive Officer)

Co-investorsAndera PartnersCatalyst Health VenturesCouncilExcelestar VenturesGood Growth CapitalKleiner Perkins+8 more

Boxbox.comin𝕏NYSE: BOXJul 2012

Box provides intelligent content management and secure collaboration for enterprise teams, combining unstructured data access and sharing with AI-powered workflows and insights.

AI & Machine LearningCloud ComputingEnterprise SoftwareSan Jose, US

Dylan Smith(Founder)inAaron Levie(Founder)inDan Levin(Director)inStephanie Carullo(Executive Officer)inPeter McGoff(Executive Officer)inGraham Younger(Executive Officer)in

Co-investorsAndreessen HorowitzBessemer Venture PartnersCoatue ManagementEmergence Capital PartnersGeneral AtlanticHercules Capital, Inc.+37 more

Braze, Inc.braze.comin𝕏NASDAQ: BRZE

Braze is a customer engagement platform that helps brands connect with customers across multiple channels.

AI & Machine LearningEnterprise SoftwareMarketing TechSaaS

Bill Magnuson(Founder)inJon Hyman(Founder)inMark Ghermezian(Founder)

Co-investors515 VenturesAccelerator VenturesBattery VenturesBlumberg CapitalBullpen CapitalCross Creek Advisors+16 more

Celcuitycelcuity.comin𝕏NASDAQ: CELC

Celcuity is a commercial-stage biotechnology company developing targeted cancer therapies for tumors involving the PAM (PI3K/AKT/mTOR) pathway, including breast, prostate, lung, endometrial, colon, and ovarian cancers.

BiotechHealthtechMedical DevicesMinneapolis, US

Lance G. Laing(Executive Officer, Director, Promoter)inBrian F. Sullivan(Executive Officer, Director, Promoter)inLance G. Laing, Ph.D.(Chief Science Officer, Vice President, Secretary and Director)Vicky Hahne(Executive Officer)in

BoardDavid F. Dalvey(Director)inRichard E. Buller(Director)

Co-investorsBrightstone Venture Capital

Champions Oncologychampionsoncology.comin𝕏NASDAQ: CSBR

Champions Oncology offers a KRAS-focused preclinical platform built on patient-derived xenograft (PDX) models screened with the pan-RAS(ON) inhibitor daraxonrasib, combining in vivo pharmacology with multi-omic characterization to study drug response and resistance.

AI & Machine LearningBiotechHealthtechHackensack, US

Ronnie Morris(Executive Officer, Director)inJames McGorry(Executive Officer)David Miller(Chief Financial Officer)inJoel Ackerman(Executive Officer, Director)inRob Brainin(Chief Executive Officer)inMaria Mancini(Chief Operating Officer)in

Co-investorsBattery VenturesIsrael Biotech Fund

Cylanceblackberry.cominNYSE: BBAcquired

BlackBerry operates two divisions focused on security and innovation: one providing end-to-end encryption and zero-trust identity control for governments and critical industries, and another offering QNX embedded software and real-time operating systems used in over 275 million vehicles worldwide.

CybersecurityEnterprise SoftwareIoTIrvine, US

Stuart McClure(Founder)inJeffrey Ishmael(Executive Officer)Mike Lazaridis(Founder)Ryan Permeh(Founder)Daniel Mendez(Founder)Prasad Wagle(Founder)

Co-investorsClearSkyCrosslink CapitalDell Technologies CapitalDraper AssociatesIn-Q-TelJunipero+10 more

Duolingoduolingo.comin𝕏NASDAQ: DUOLSep 2012 · $45M

Duolingo offers app-based language learning through short, game-like lessons that teach reading, writing, listening, and speaking, using AI and language science to personalize the experience.

AI & Machine LearningConsumerEdTechPittsburgh, US

Severin Hacker(Founder)inLuis von Ahn(Founder)inMatt Skaruppa(Chief Financial Officer)inSeverin Guey(Founder)in

BoardBrad Burnham(Director)inAndrew Moore(Director)

Co-investorsCapitalGDrive CapitalFelicis VenturesFirebolt Ventures Management Company, LlcGeneral AtlanticK2 Global+10 more

Elasticelastic.coin𝕏NYSE: ESTCJun 2014

Elastic develops search-powered software for enterprises, offering products for search, observability, and security built on Elasticsearch.

AI & Machine LearningCloud ComputingCybersecurityData & InfrastructureDeveloper ToolsEnterprise SoftwareSan Francisco, US

Teunis Steven Schuurman(Director)Steven Schuurman(Founder)Uri Boness(Founder)inSimon Willnauer(Founder)inShay Banon(Founder)inW.H. Baird Garrett(Executive Officer)in

Co-investorsAmplify PartnersDCVC (Data Collective)Index VenturesNight CapitalNorwest Venture PartnersSierra Ventures+3 more

Enliven Therapeuticsenliventherapeutics.cominNASDAQ: ELVN

Enliven Therapeutics is a clinical-stage biopharmaceutical company that discovers and develops small molecule therapeutics using a precision medicine approach, with a focus on oncology and hematology.

BiotechHealthtechBoulder, US

Sam Kintz(Co-founder and Head of Pipeline)inJoe Lyssikatos(Co-founder and Research Fellow)Anish Patel(Co-founder and Chief Operating Officer)Rick Fair(Chief Executive Officer and Member of the Board of Directors)inHelen Collins(Chief Medical Officer)inBen Hohl(Chief Financial Officer and Head of Corporate Development)in

Co-investors5AM VenturesOrbiMedPfizer Venture InvestmentsRoche Venture FundARCH Venture PartnersBay City Capital+2 more

Fiscal Notefiscalnote.comin𝕏OTC: NOTEJan 2013

FiscalNote provides AI-powered software that aggregates and interprets legislative and regulatory data to help organizations track and influence policy outcomes.

AI & Machine LearningData & InfrastructureGovTechSaaSWashington, US

Tim Hwang(Founder)inGerald Yao(Founder)inJonathan Chen(Founder)inPaul Donnell(Chief Accounting Officer)inJon Slabaugh(CFO and Senior VP of Corporate Development)inRichard Henderson(Executive Officer)in

Co-investors1802 Ventures645 VenturesArrowroot CapitalChaac VenturesConversion CapitalDorm Room+25 more

Force10dell.cominNYSE: DELL

Dell designs and sells computing hardware including laptops (XPS, Alienware gaming), monitors, webcams, and PowerEdge servers, along with IT lifecycle management and support services.

ConsumerEnterprise SoftwareHardwareRound Rock, US

Michael Dell(Chairman & CEO)in

Co-investorsIcon VenturesJackson Square VenturesPartners for GrowthUtah Governor’s Office of Economic Development (GOED)

Gerongeron.cominNASDAQ: GERN

Geron is a biopharmaceutical company focused on developing therapies for blood cancer.

BiotechHealthtechLongevityMedical Devices

Michael D. West(Founder)Harout Semerjian(President and Chief Executive Officer)inMichelle J. Robertson(Executive Vice President, Chief Financial Officer, Treasurer and Interim Secretary)inJoseph Eid(Executive Vice President, Research and Development, Chief Medical Officer)inAhmed ElNawawi(Executive Vice President, Chief Commercial Officer)in

Co-investorsBioBritVenrockDomain Associates

Gossamer Biogossamerbio.comin𝕏NASDAQ: GOSS

Gossamer Bio is a clinical-stage biopharmaceutical company developing seralutinib, an investigational drug candidate for treating pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

BiotechDigital HealthMedical DevicesSan Diego, US

Faheem Hasnain(Executive Officer, Director)inChristian Waage(Executive Officer)inSheila Gujrathi, MD(Founder)inBryan Giraudo(Executive Officer)Laura Carter, Ph.D.(Executive Officer)Robert Smith(Executive Officer)

Co-investorsARCH Venture PartnersBay City CapitalEcoR1 CapitalFoothill VenturesPivotal Life SciencesSamsara BioCapital+3 more

Groupon, Inc.groupon.comin𝕏NASDAQ: GRPN

Groupon operates a marketplace connecting consumers with discounted deals from local and national merchants across restaurants, beauty services, travel, entertainment, and retail products.

E-commerceMarketplacesRetail Tech

Andrew Mason(Founder)inDusan Senkypl(Chief Executive Officer)inJiri Ponrt(Chief Operating Officer)inRana Kashyap(Chief Financial Officer)inBrad Keywell(Founder)Eric Lefkofsky(Founder)in

Co-investorsAccelAndreessen HorowitzBattery VenturesInterlace VenturesMaveronPale Fire Capital+7 more

ImaraNASDAQ: ELVNMar 2019 · $63Macquired by Enliven Therapeutics · Feb 2023

Imara is a clinical-stage biopharmaceutical company developing small molecule therapeutics for unmet medical needs, currently advancing ELVN-001, a selective kinase inhibitor designed to treat chronic myeloid leukemia by targeting the BCR-ABL gene fusion.

BiotechCambridge, US

James G. McArthur(Executive Officer, Director)Christoph M. Adams(Executive Officer, Director)Richard Fair(President, Chief Executive Officer, Director)

BoardSara Nayeem(Director)Barbara Dalton(Director)David Mott(Director)

Co-investorsBay City CapitalPfizer Venture InvestmentsRA CapitalAlexandriaArix BioscienceJMI Equity+3 more

Iridex Corporationiridex.comin𝕏NASDAQ: IRIX

Iridex makes laser systems, EndoProbe handpieces, and vitreoretinal surgical consumables used for precision eye surgery in hospitals and ambulatory surgery centers.

HardwareHealthtechMedical DevicesMountain View, US

Patrick Mercer(Chief Executive Officer)inRomeo Dizon(Executive Officer)

BoardYu-Hao Chen(Director)Scott Shuda(Director)William Moore(Director)Beverly Huss(Director)

Co-investorsIncubic Management LLC

Korro Biokorrobio.comin𝕏NASDAQ: KRROMay 2019 · $70M

Korro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology.

BiotechHealthtechCambridge, US

Nessan Bermingham(Mr. Bermingham is the Executive Chair of the Issuer.)inJean-François Formela(Director)inOmmer Chohan(Mr. Chohan is the Secretary and Treasurer of the Issuer.)inRam Aiyar(Chief Executive Officer, President and Director)inTodd Chappell(Chief Operating Officer)in

Co-investorsAtlas VentureMC Healthcare VenturesAlexandriaQiming Venture PartnersQiming Venture Partners USARock Springs Capital+3 more

Lexicon Pharmaceuticalslexpharma.cominNASDAQ: LXRX

Lexicon Pharmaceuticals develops and commercializes pharmaceutical products, including the marketed drug INPEFA and drug candidates in clinical development such as sotagliflozin, pilavapadin, and LX9851, serving patients in need of treatments across various therapeutic areas.

BiotechThe Woodlands, US

Brian P. Zambrowicz(Executive Officer)inBrian T. Crum(Executive Officer)inRachel Martens(Executive Officer)inScott Coiante(Executive Officer)Craig B. Granowitz(Executive Officer)inWendy E. McDermott(Executive Officer)in

Liquidia Corporationliquidia.cominNASDAQ: LQDAApr 2021

Liquidia develops and commercializes inhaled and injectable therapies for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

BiotechMorrisville, US

Damian deGoa(Executive Officer, Director)inMichael Kaseta(Executive Officer)in

BoardPaul B. Manning(Director)inStephen Bloch(Director)inJoanna Horobin(Director)Raman Singh(Director)

Co-investorsCanaan PartnersXeraya CapitalPBM Capital

Marker Therapeuticsmarkertherapeutics.cominNASDAQ: MRKR

Marker Therapeutics develops novel T cell therapies, including adoptive T cell therapy approaches, for clinical applications in oncology and other diseases with high unmet need.

BiotechHealthtechHouston, US

Juan Vera(Executive Officer, Director)inDr. Vera(Co-founder)Glynn Wilson(Executive Officer, Director)John Bonfiglio(Executive Officer, Director)

BoardSteven Elms(Director)inJohn Wilson(Director)

Co-investorsAisling Capital

Mirna Therapeuticsblogmedicina.com𝕏OTC: SYBX

A Spanish-language blog that publishes articles on health and medicine topics, such as flu prevention and vaccination recommendations, for general readers.

BiotechMedia & EntertainmentAustin, US

Matthew Winkler(Director)Sinil Kim(Executive Officer)inPaul Lammers(Executive Officer, Director)inJon Irvin(Executive Officer)Casi DeYoung(Executive Officer)

BoardMichael Powell(Director)

Co-investorsPfizer Venture InvestmentsCorrelation VenturesOrbiMedOUP (Osage University Partners)Pfizer VenturesSofinnova Ventures

MongoDBmongodb.comin𝕏NASDAQ: MDBDec 2014

MongoDB is a cloud database company that provides Atlas, a multi-cloud data platform for transactional, search, and generative AI workloads, along with enterprise on-premises options and integration tools for developers and partners.

AI & Machine LearningCloud ComputingData & InfrastructureDeveloper ToolsNew York, US

Dwight Merriman(Founder)inEliot Horowitz(Founder)inChirantan 'CJ' Desai(President and Chief Executive Officer)Sydney Carey(Chief Financial Officer)inDev Ittycheria(Chief Executive Officer)inAlexander Stigsen(Founder)in

Co-investorsAlleyCorpDell Technologies CapitalFlybridge Capital PartnersFoundryIn-Q-TelMaC Venture Capital+7 more

Nektar Therapeuticsnektar.cominNASDAQ: NKTR

Nektar develops therapies that modulate the immune system to treat autoimmune diseases and inflammatory conditions, targeting the root causes of immune dysfunction.

BiotechHealthtechSan Francisco, US

Howard W. Robin(Executive Officer, Director)Gil M. Labrucherie(Executive Officer)inManinder Hora(Executive Officer)inStephen K. Doberstein(Executive Officer)John Nicholson(Executive Officer)Jillian B. Thomsen(Executive Officer)

Co-investorsHEALTHCARE ROYALTY PARTNERS

NeuroPaceneuropace.comin𝕏NASDAQ: NPCEAug 2020

NeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.

Digital HealthHardwareHealthtechMedical DevicesMountain View, US

Rebecca Kuhn(Executive Officer)inFrank Fischer(Executive Officer, Director)Joel Becker(President, Chief Executive Officer and Director)inVince Burgess(Director)inRenee Ryan(Director)inRay Larkin(Director)

Co-investorsAccelmed PartnersOrbiMed

Nextnavnextnav.comin𝕏NASDAQ: NN

NextNav builds positioning, navigation, and timing (PNT) services using spectrum as a complement and backup to GPS, addressing vulnerabilities in indoor, urban, and critical infrastructure environments.

Deep TechDefense TechIoTSpace TechReston, US

Arun Raghupathy(Co-Founder and Chief Technology Officer)inGanesh Pattabiraman(Chief Executive Officer)MARIAM SOROND(Executive Officer, Director)inSUSAN INSLEY(Executive Officer)inJAMES BLACK(Executive Officer)inCHRISTIAN GATES(Executive Officer)in

Co-investorsColumbia CapitalOak Investment Partners

Omada Healthomadahealth.comin𝕏NASDAQ: OMDA

Omada Health provides virtual-first, integrated care programs for chronic disease management, delivered as data-driven solutions for employers, health plans, and healthcare organizations.

Digital HealthHealthtechWellness & FitnessSan Francisco, US

Andrew DiMichelle(Executive Officer, Director)Adrian James(Founder)inSean Duffy(Founder)inWei-Li Shao(President)inSteve Cook(Chief Financial Officer)inAndrew DiMichele(Founder)

Co-investorsaMoonAndreessen HorowitzBlackbird VenturesCanvas VenturesCivilization Ventures Management, LlcDesigner Fund+18 more

Opendooropendoor.comin𝕏NASDAQ: OPENJun 2018

Opendoor offers instant cash offers for residential properties through real estate agents, allowing sellers to choose between a fast sale or list the home later.

B2B MarketplacesE-commerceMarketplacesPropTechPhoenix, US

Eric Wu(Founder)inJD Ross(Founder)Keith Rabois(Founder)inKaz Nejatian(Chief Executive Officer)inIan Wong(Founder)

Co-investorsA*Access Technology VenturesAirTree VenturesAndreessen HorowitzBlue LionBlue Lion Global+42 more

ORIC Pharmaceuticalsoricpharma.cominNASDAQ: ORIC

ORIC Pharmaceuticals is a clinical-stage oncology company developing therapies aimed at overcoming cancer treatment resistance, including innate, acquired, and bypass resistance.

BiotechHealthtechSouth San Francisco, US

Richard Heyman(Chairman, Founder, Scientific Advisory Board)inCharles Sawyers(Founder, Scientific Advisory Board)Scott Lowe(Founder, Scientific Advisory Board)Dominic Piscitelli(Chief Financial Officer)inPratik Multani(Chief Medical Officer)inJacob Chacko(President, Chief Executive Officer and Board Member)in

Co-investorsEcoR1 CapitalNextech InvestTaiho Ventures, LLCThe Column GroupViking GlobalOrbiMed

PagerDutypagerduty.comin𝕏NYSE: PD

PagerDuty provides a platform for incident response and operations management that enables teams across technical and business functions to respond to critical events in real time.

AI & Machine LearningCloud ComputingDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US

Alex Solomon(CTO)inDan Alexandru Solomon(Director)Jennifer Tejada(Executive Chair)inSteven Gatoff(Executive Officer)inJohn DiLullo(Chief Executive Officer)inBaskar Puvanathasan(Software Engineer / Product Manager)

Co-investorsAccelAndreessen HorowitzAurumBaseline VenturesBessemer Venture PartnersBling Capital+17 more

PayPalpaypal.cominNASDAQ: PYPLFeb 2025 · $63M

PayPal Ads is an advertising business that uses transaction data from PayPal's payment network to offer targeted onsite, offsite, and offer-based ads for businesses.

AdTechFintechMarketing TechSan Jose, US

Max Levchin(Founder)inPeter Thiel(Founder)inLuke Nosek(Founder)inKen Howery(Founder)inElon Musk(Founder)inAlex Chriss(President and Chief Executive Officer)in

Co-investorsA*BlueRun VenturesClearstone Venture PartnersDG Daiwa VenturesMercury FundPlug and Play Ventures+6 more

Sagimet Biosciencessagimet.cominNASDAQ: SGMTFeb 2019 · $18M

Sagimet is a clinical-stage biopharmaceutical company developing therapies targeting fatty acid synthase (FASN) for metabolic diseases and oncology.

BiotechDigital HealthHealthtechMenlo Park, US

Rekha Hemrajani(Executive Officer)inMerdad Parsey(Executive Officer, Director)inDavid Happel(Chief Executive Officer & Director)Andreas Grauer(Chief Medical Officer)inThierry Chauche(Chief Financial Officer)inMarie O'Farrell(Chief Scientific Officer)in

Co-investorsAltium CapitalHM Venture PartnersKleiner PerkinsBAM ElevateBiotechnology Value FundBlue Owl Capital+1 more

Salesforcesalesforce.cominNYSE: CRM

Salesforce provides an AI-powered customer relationship management (CRM) platform that unifies sales, service, marketing, commerce, and IT, with agentic AI and connected data to automate workflows and customer interactions.

AI & Machine LearningEnterprise SoftwareSaaSSan Francisco, US

Parker Harris(Founder)inMarc Benioff(Founder)inAmy E. Weaver(Executive Officer)inBret Taylor(Executive Officer)inCindy Robbins(Executive Officer)inGeorge Hu(Executive Officer)in

Co-investorsEmergence Capital PartnersKyber Knight CapitalMeritech Capital PartnersRichmond Global VenturesRuna CapitalAccel+9 more

Savarasavarapharma.cominNASDAQ: SVRA

Savara is a biopharmaceutical company developing treatments for autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and other rare lung diseases.

BiotechHealthtechMedical DevicesAustin, US

Matt Pauls(Chair of the Board of Directors and Chief Executive Officer)inMike Ciesla(Executive Officer)Badrul Chowdhury(Executive Officer)inSantosh J. Vetticaden(Executive Officer)Gregory D. Gorgas(Executive Officer)Patrick Keran(Executive Officer)

Co-investorsBain Capital Life SciencesCentral Texas Angel NetworkGreen Park & Golf VenturesKeiretsu ForumMoore Venture Partners

SenseonicsNASDAQ: SENS

Senseonics develops and commercializes an implantable continuous glucose monitoring system called Eversense that measures blood glucose levels for extended periods (up to 12 months) via a subcutaneous sensor and rechargeable transmitter, serving people with diabetes as an alternative to conventional CGM devices that require replacement every 1-2 weeks.

BiotechGermantown, US

Mirasol Panlilio(Executive Officer)inR. Don Elsey(Executive Officer)Mukul Jain(Executive Officer)Timothy T. Goodnow(Executive Officer, Director)Francine R. Kaufman(Chief Medical Officer)inBrian Hansen(Chief Commercial Officer)

Senseonics Holdingssenseonics.comNASDAQ: SENS

Senseonics develops and commercializes Eversense, an implantable continuous glucose monitoring system designed to measure blood sugar levels for up to one year in people with diabetes, offering an alternative to conventional glucose monitors that require more frequent sensor replacement.

BiotechGermantown, US

Mukul Jain(Executive Officer)Francine R. Kaufman(Executive Officer, Director)inRick Sullivan(Executive Officer)inKenneth L Horton(Executive Officer)Timothy T. Goodnow(Executive Officer, Director)Mirasol Panlilio(Executive Officer)in

Co-investorsRoche Venture FundVensana Capital

Snapsnapchat.cominNYSE: SNAPApr 2014

Snapchat is a mobile app for communicating with friends and family through photos and videos, featuring augmented-reality Lenses, creative sharing tools, and a personalized map for discovering places and content.

ConsumerCreator EconomyMedia & EntertainmentSocialSanta Monica, US

Evan Spiegel(Founder)inBobby Murphy(Founder)Reggie Brown(Founder)Tim Sehn(Executive Officer)Emily White(Executive Officer)inDerek Andersen(Chief Financial Officer)in

Co-investorsA-Rod CorpAccess Technology VenturesAlibaba GroupCapitalGCoatue ManagementEntrée Capital+40 more

Sprinklr, Inc.sprinklr.comin𝕏NYSE: CXMApr 2014

Sprinklr provides an AI-native customer experience platform that manages feedback, customer interactions, and contact center operations across multiple channels.

AI & Machine LearningEnterprise SoftwareMarketing TechSaaSNew York, US

Ragy Thomas(Founder)inMurali Swaminathan(Executive Officer, Director)inChristopher Lynch(Executive Officer)Carlos Dominguez(Director)inRory Read(President and Chief Executive Officer)in

BoardCarey Lai(Director)in

Co-investorsAzure Capital PartnersBattery VenturesConductive VenturesHellman & FriedmanICONIQJC2 Ventures+8 more

Surf Airsurfair.comin𝕏NYSE: SRFM

Surf Air Mobility operates regional air travel across the U.S. through scheduled flights, on-demand private charter booking, and electric aviation technology.

CleantechMobility & TransportationTravel & HospitalityHawthorne, US

Sudhin Shahani(Director)inOliver Reeves(Executive Officer)Tyler Painter(Director)Deanna White(Executive Officer)inJames Bailey(Director)Bruce Gonzalez(Executive Officer)

Co-investorsAnthem Venture Management, LlcBaroda VenturesBase Venture Management, Inc.Ff Venture CapitalMucker CapitalPartners for Growth+6 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Aptive SystemsArazAset TherapeuticsBranch Metrics, Inc.Bright HealthComplexaCurzion Pharmaceuticals IncCydan IIEBH HoldingExploraMed NC7FirstLight Bio, Inc.Flow CommerceGoEuroLaunchpad Therapeutics, Inc.Nexo Therapeutics, Inc.Nusantara HoldingsOne ConcernRetrieve TechnologiesRocket.Chat Holdings, Ltd.SnagfilmsSolace TherapeuticsStable Coin Inc.

Browse all 1,231 investments with full details →

▶1,000 more tracked companies (of 1,031)

TectusTesaroThreatQuotientTiger DataToloka GroupTravelatorTulipTune TherapeuticsTwelve LabsUniphoreVirgin PulseVori HealthWaltz NetworksWaymarkWizard CommerceWonder GroupX9, Inc.ZeroFox011BOG22223andMe3Com Corporation3ware42Floors4351offerAcadia PharmaceuticalsAcclarentAccordanceAciexAcquiaAcrivon TherapeuticsActions Semiconductor Co., Ltd.AddThisAdvanced CardiovascularAelurosAeraAerohive NetworksAerospikeAetionAffimedAffinia TherapeuticsAgreeAI FundAI SquaredAir WorksAjax Vascular, Inc.AlconAlexza PharmaceuticalsAlfredAlienVaultAlimerasciencesAllakos IncAllay TherapeuticsAlteon WebsystemsAmber TherapeuticsAmerican Pathology PartnersAmerigroup CorporationAmicus TherapeuticsAMISYS Managed CareAmplyxAmplyx PharmaceuticalsAnacorAneuRxAnnexonAntenna SoftwareAnteriorAntimatterAntimatterAntimatterAnyscaleAnywhereAnywhereAppianApplixApprendaAppriva MedicalAquabyteAquantiaArchieArcsightArdelyxArgon NetworksArrisARRIS CompositesAscend CommunicationsAssembledAstral PointAtheros CommunicationsAthiraAtriumAttestAudienceAugustAurelianAurinia PharmaceuticalsAvailinkAvenzoAVEO OncologyAviadoBioBackflipBackflip AIBaihe Holding CorporationBarkly ProtectsBasaltBasalt HealthBay Networks (Wellfleet Comm)BCD SemiconductorBeachMintBedRocket MediabeehiivBellyBenchPrepBerkeley NetworksBerkshire GreyBestowBethesda Research LabsBig Data FederationBlack DuckBlacktagBliqBlock RenovationBlockCypherBlockCypher Blockchain web servicesBloomreach, Inc.Blue CheetahBlue Jeans NetworkBlue OceanBlue Shift LabsBluefishBluefish AIBNTOBNTOBNTOBoingo WirelessBokuBonsaiBonsaiBoxcarBraintreeBranchBranchBrandlessBravo HealthBrenig Therapeutics, Inc.BridgePoint MedicalBright Health GroupBrightkiteBroadlyBroadview Network HoldingsBytedanceCadence PharmaceuticalsCambiumCandy DigitalCanopyCanopy TaxCanopy Technology CorpCardioThoracic SystemsCardiovascular Imaging SystemsCardurionCardurion PharmaceuticalsCare.comCareerBuilderCarezoneCarrier Access CorporationCarticept MedicalCartivaCascadian TherapeuticsCasperCasperCasper'sCatalogCatalogCatalyst BiosciencesCathay Industrial Biotech, Ltd.CausesCCP GamesCentralizeCentrexion TherapeuticsCeramic AICerecor Inc.ChanneladvisorChaosCHAOSCharmCharmCharmCHARM TherapeuticsChelsio CommunicationsCHG HealthcareChina Gtel LimitedChina Health (CITIC)ChromaCodeCirrus LogicCistaClarifaiClarifyClarify AIClarVista MedicalClearMetalClearMotionClearspring TechnologiesCleave BiosciencesClementiaCleoCleversafeClioClockwork SystemsCloudflare, Inc.Clovis OncologyCodaCode 42Code BiotherapeuticsCoEditionCogenesysCollective HealthCom21ComancheComanche BiopharmaCompass LabsComprehensive Pharmacy ServicesConceptusContraConvivaCorcaCorcaCorvisCorxelCotopaxiCoupleCourtyardCourtyard.ioCowboy Space CorporationCrewLABCrowdMedCTI BiopharmaCuralateCurana HealthCurisiumCusp AiCV IngenuityCV TherapeuticsCventCyberMediaCyenceCyras SystemsDallas SemiconductorDandelion EnergyDandelion HealthData DomainDatabentoDatabricksDatalogixDatriumDaVita NephrolifeDecruDeltaStreamDermiraDesire2LearnDesktop MetalDevices for Vascular InterventionDevyceDiamond TherapeuticsDiatideDidiDivvyDivvyDivvyDjustDocentDOTS Technology CorpDroboDropDropDropDropDropDSI RenalDura PharmaceuticalsE*OfferingE2O CommunicationsEargoEarlenseBenxEcho Global LogisticsEchodyneEchopass CorporationECI Acquisition HoldingseConvergentEdelman Financial EnginesEdmodoEkoEko HealthElement3 HealthElevenLabsElionEmbraceEmbraceEmbraneEnceladusEnceladus BioEndocardial SolutionsEndotexEngine YardEnginesEnigmaEnzytechEpix TherapeuticseRoomErytech PharmaEscient PharmaceuticalsESP PharmaEsprit PharmaEucalyptus SystemsEuclid AnalyticsEvalveEvenlyEventUpEverFiEvernoteEvernowEversideEverside HealthExent TechnologiesExpanseExpelExploraMedFabFitFunFactoryFactoryFanhattanFanhouseFastinoFeatherFenris GamesFibexFieldglassFiftyThreeFightCampFinancial EnginesFinancial Software & SystemsFineground NetworksFIRE1FirebaseFirst CryFisker AutomotiveFisker AutomotiveFizzFlowFlowFlowFlowFlowFlowFlowFlow48FlutterFollozeForerunnerForesightForesightForethought Technologies, Inc.FormlabsForterFox Hollow TechnologiesFramebridgeFreoFreshplumFriskaiFrontier Car GroupFTX FundFTX USFugueFulcrum MicrosystemsFunctional FinanceFusion I/OFusionOpsFyusionGaikaiGaikaiGainspeedGalera TherapeuticsGeistMGeltex PharmaceuticalsGen.GGenetic Therapy Inc.GeniesGenmoGeoTel CorporationGilt GroupeGlacierGlacierGladlyGlamsquadGlobal Savings GroupGlobalLogicGloucester PharmaceuticalsGLU MobileGlycomimeticsGOATGOAT GroupGoji SolutionsGolden AnalyticsGolden State Medical SupplyGoodGuideGoodLeapGoodLeap 🦄GoodyGoopGraftGrand JunctionGraphite SystemsGravelGreat JonesGreenlightGreoGrey RhinoGreycroftgreytHRGridPointGrowth NetworksGuardentGuidelineGuideSparkGumGumGynecareH2CorporationHabitat HealthHackerOneHannunHealthsouthHeapHearsayHeavyHemoSenseHiredHireguideHockeyStackHorizon TherapeuticshosHouse RxHouzzHowlHydra BiosciencesHYGEIA Medical Services GroupHyperfairHyperion TherapeuticsIdfyIfOnlyIFTTTIgneousIgneous SystemsIIXillusive networksIllusivenetworksiManageImmigramImmunex CorporationImmunomedicsIn HouseIn-House HealthIncareyIndioInfinity PharmaceuticalsInfluitive CorporationInfoGear TechnologyInfoworksInhibitexInkittInnerWorkingsInozyme PharmaInporiaInSoftInstabaseIntact VascularIntact VascularIntarcia TherapeuticsIntelligenceNODEIntellisysInterleukin GeneticsInterMuneInventivaInversagoIomai CorporationIOpipeISGN Technologies Ltd.Jet.comJoinfizzJomboy MediaJuniper NetworksJuvoJyveKaazingKaizenKaizen LabsKeelvarKetraKhoros(formerly Lithium Technologies)KindredKiraKiraKiraKISWEKnotchKoalaKongKONUXKorroKoudaiKumuKumu NetworksLanditLanditLatitudeLatitudeLatitude dataLattice EnginesLaurel NetworksLayerLearnUpLedgeLedgyLegato MedicalLemonadeLeonaBioLetgoLianLianLife TechnologiesLily AILimitlessLinekong International Co., Ltd.LithiumLithium TechnologiesLittle LabsLiveLoopLiza HealthLizzy AiLogikcullLong Term Care GroupLooptLoreLoreLoxo OncologyLumenaLuminalLuminaryLuminary MicroLuminate WirelessLumos PharmaLungpacer MedicalLuxteraLXAMacromediaMage LegalMagenta MedicalMainstream DataMaintainXMapD TechnologiesMarathon HealthMarketoMartianMashginMaster ClassMatroidMattermarkMayhemMayhem SecurityMBX BiosciencesMediaoceanMediSys EduTechMEI Pharmamejuri storyMergeMergeMERGEMerlinMersana TherapeuticsMetabaseMetacrineMetaventionMetromilemi|imMicro FocusMighty AIMighty AIMighty AIMiiMMillennial MediaMimosa Networks IncMindeeMindTickleMinimumMission Critical SoftwareMissMaliniMobiSocialMobius Management SystemsModa OperandiModyfiMojo VisionMoonPayMore HealthMotion ComputingMotricityMotus TherapeuticsMovius Interactive CorporationMulesoftMyFitMyogenNaaptolNaked LabsNamespaceNationwide Remittance CentersNefeli NetworksNellcorNeo CyberneticaNeoterisNeoTractNetIQNetSolveNeueHealthNeural MagicNeuralieveNeutral TandemNevroNew Globe EducationNEW WAVENew Wave FoodsnewScaleNexchemNexImmuneNext Power 360NG.CASHnginxNginxNiaraNiciraNiciraNicira NetworksNightstarNimble CollectiveNimble StorageNinjaOneNitraNkarta TherapeuticsNodeNodeNoonlightNordsenseNova FertilityNovaceptNovast Holdings LimitedNovatiumNth RoundNuelleNuvoloOANDAObsEvaOculeveOhaiOmioOmthera PharmaceuticalsOnshapeOnStreamOpowerOrbis MedicinesOrby AIOrexigen TherapeuticsOricOrigin MedsystemsOrphoMedOuro MedicinesOyster PointOzonePacketeerPagerPair EyewearPanacea Medical TechnologiesPantheonParc PlacePatientKeeperPatreonPcOrderPegasystemsPentahoPentahoPeplinPerplexityPersonal Genome DiagnosticsPharmionPhaseBio PharmaceuticalsPhathom PharmaceuticalsPhiloPhysical IntelligencePicabooPILOT AI LABS, INC.Pinnacle EnginesPionyr ImmunotherapeuticsPixieBrixPlacemeterPlaidPlatoPlatoPlay Versus Inc.PlaydomPlayers TribunePlayVSPluribus NetworksPlusmoPocketPocketPolyservePomelloPopaiPoppy Handcrafted PopcornPortAuthorityPositron AIppoNEXTPredictive BiosciencesPrelayPrime Financial TechnologiesProcketProgress SoftwareProofoflearnPropense AIProsensaProteostasis TherapeuticsProxima TherapeuticsPsyadon PharmaceuticalsPulsePulsePure EnergiesPyxisQpex BiopharmaQualifiedQuantum Bridge CommunicationsQuidsi (Diapers.com)QuillQuoteWellRa PharmaceuticalsRaiseRAISERapid RoboticsRavelReachifyRecludixRedbabyRefresh ClubRegression GamesRegulusRegulus Therapeutics Inc.Relay VenturesRelievant MedsystemsReltioReneoReneo PharmaceuticalsRepros TherapeuticsResilienceResilienceRetrieveRevelioRevelle AestheticsRevSpringRewind AIRF MonolithicsRf SurgicalRigel PharmaceuticalsRingCubeRock HealthRocketRocketROCKETRuntimeRx RedefinedSafeBaseSafeRide HealthSafeTrekSakana AISalixSamaya AISanaSana LabsSaphoSasken CommunicationsSatori PharmaceuticalsSavara PharmaceuticalsSaveSAY MediaSBCSCI SolutionsScopely, Inc.Scout RFPScoutibleScratch Music GroupSeattle GeneticsSegmentSemiconductor Manufacturing International Corporation (SMIC)SengledSentonsSentrySepracorSeragon PharmaceuticalsSerious EnergySierra AtlanticSilicon Blue TechnologiesSilicon GraphicsSilicon SpiceSimple HabitSimple PsychologySimpleRoseSimplex HealthcareSimsolidSingleStoreSingularitySisuSisu DataSiTimeSiTime Corporation (米国)SlashSleep ResetSlopeSlopeSmartDrive Systems, Inc.SnowplowSocialRadarSolar JunctionSolidFireSolta MedicalSome Spider StudiosSonatypeSonic InnovationsSora SchoolsSORAASourcefireSourcery.AISpectrianSpektrSpektrSpine WaveSpirationSplice BioSpoknSpreadtrum CommunicationsSpring Mobile SolutionsSpringpathSproutStablixStarcityStashStemcentrxStormpathStreamSetsStride HealthStrive HealthStrongbridge BiopharmaSubtextSubtextSugarAISugarCRMSun EdisonSunDeckSunesisSuperSuperGenSupernus PharmaceuticalsSupplyBaseSurface OncologySurgical HealthSurgRxSwift NavigationSwiftypeSwirldsSwitchOn NetworksSyllableSynthesiaTableauTableau SoftwareTabulaTabulaTagkastTagworksTagworks PharmaceuticalsTailorTamrTarveda TherapeuticsTealTeal DronesTechnical CommunitiesTele AtlasTelebit CorpTelegent SystemsTempest TherapeuticsTenerosTeracentTestMartThankfulThe Climate CorporationThe FoundryThe Players TribuneThe WellThe WingThe WingThe YesTheorycraft GamesTherachonThirdLoveThunkableTiburio TherapeuticsTidal TherapeuticsTidemarkTiger Data (creators of TimescaleDB)TigeraTintriTivoTogether AITokenzToperaTopiaTrackMavenTRACON PharmaceuticalsTractTrading DynamicsTranscept PharmaceuticalsTransfixTransifexTranslucent AITransvascularTravelbankTrevenaTri Alpha EnergyTrillium TherapeuticsTripodtriValenceTrivascularTuriTwelveTwenty (YC S23)U First CapitalU S Renal CareUhanaUlinkUltheraUltraDNSUnboundUnifyIDUnionUpskillUpworthyUrsaUrsa Space SystemsUUNETValley SteerValueFirstVantage OncologyVAST DataVeloCloudVenmoVeriflowVerona PharmaVertex PharmaceuticalsVerticaVertiFlexVezaViddyViddyVideologyVimaan RoboticsViracta Therapeutics (formerly Sunesis)VirataVirtelaVirtruVishwaVitae PharmaceuticalsVitesse SemiconductorVividCortexVixs SystemsVizbeeVocalocityVtesseVuclipVytronUSWallapopWaymarkWebExWebEx CommunicationsWebMD (Healtheon)WelltokWheelhouseWheelhouseWheelsWheels UpWiiTHWillowWillowWillowWireWheelWispr FlowWit.AIWizardWNP Communications

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 170

74 IPOs · 96 acquisitions · showing 72

Monte Rosa TherapeuticsNASDAQ: GLUEBuzzFeedNASDAQ: BZFDCourseraNYSE: COURCVRxNASDAQ: CVRXMirum PharmaceuticalsNASDAQ: MIRMNextNav HoldingsNASDAQ: NNNkarta, Inc.NASDAQ: NKTXOnkure Therapeutics IncNASDAQ: OKURRobinhoodNASDAQ: HOODSenti BiosciencesNASDAQ: SNTISprout Social, Inc.NASDAQ: SPTSpyglass PharmaNASDAQ: SGPSynlogicOTC: SYBXTempusNASDAQ: TEMTwilioNYSE: TWLOActelis NetworksOTC: ASNSAdaptimmuneOTC: ADAPYAddex TherapeuticsNASDAQ: ADXNAkari TherapeuticsNASDAQ: AKTXAmplitudeNASDAQ: AMPLBlack Diamond Therapeutics, IncNASDAQ: BDTXBloom EnergyNYSE: BEBoston ScientificNYSE: BSXBoxNYSE: BOXBraze, Inc.NASDAQ: BRZECelcuityNASDAQ: CELCChampions OncologyNASDAQ: CSBRCylanceNYSE: BBDuolingoNASDAQ: DUOLElasticNYSE: ESTCEnliven TherapeuticsNASDAQ: ELVNFiscal NoteOTC: NOTEForce10NYSE: DELLGeronNASDAQ: GERNGossamer BioNASDAQ: GOSSGroupon, Inc.NASDAQ: GRPNImaraNASDAQ: ELVNIridex CorporationNASDAQ: IRIXKorro BioNASDAQ: KRROLexicon PharmaceuticalsNASDAQ: LXRXLiquidia CorporationNASDAQ: LQDAMarker TherapeuticsNASDAQ: MRKRMirna TherapeuticsOTC: SYBXMongoDBNASDAQ: MDBNektar TherapeuticsNASDAQ: NKTRNeuroPaceNASDAQ: NPCENextnavNASDAQ: NNOmada HealthNASDAQ: OMDAOpendoorNASDAQ: OPENORIC PharmaceuticalsNASDAQ: ORICPagerDutyNYSE: PDPayPalNASDAQ: PYPLSagimet BiosciencesNASDAQ: SGMTSalesforceNYSE: CRMSavaraNASDAQ: SVRASenseonicsNASDAQ: SENSSenseonics HoldingsNASDAQ: SENSSnapNYSE: SNAPSprinklr, Inc.NYSE: CXMSurf AirNYSE: SRFMTrevi TherapeuticsNASDAQ: TRVITuyaNYSE: TUYAUberNYSE: UBERUpstartNASDAQ: UPSTUpworkNASDAQ: UPWKVistaGen TherapeuticsNASDAQ: VTGNWorkdayNASDAQ: WDAYX4 PharmaNASDAQ: XFORXenon PharmaceuticalsNASDAQ: XENEZenas BiopharmaNASDAQ: ZBIOCatalyticacq. by PagerDutyCurzion Pharmaceuticals Incacq. by Horizon Therapeutics

Portfolio news

latest coverage across their companies

Fund performance · per public LP disclosures · 19

as of Sep 2025
FundVintageCommittedNet IRRTVPIDPI
NEA SH 2025 SPVLPs: Orange County Employees Retirement System2025——1.00x—
NEA 18 VentureLPs: Los Angeles City Employees' Retirement System2022—1.8%1.03x0.00x
NEA 18 Venture Growth EquityLPs: California State Teachers' Retirement System, Los Angeles City Employees' Retirement System, Orange County Employees Retirement System2022—11.6%1.20x—
New Enterprise Associates 18LPs: Nebraska Investment Council, Los Angeles City Employees' Retirement System, California State Teachers' Retirement System +2 more2022—40.5%1.86x0.11x
New Enterprise Associates 18rLPs: Orange County Employees Retirement System2022—41.0%2.00x0.11x
New Enterprise Associates 17LPs: California State Teachers' Retirement System, Nebraska Investment Council, Los Angeles City Employees' Retirement System +2 more2019—4.5%1.17x0.16x
New Enterprise Associates 16LPs: California State Teachers' Retirement System, Sacramento County Employees' Retirement System, Los Angeles City Employees' Retirement System +1 more2017—8.2%1.52x0.42x
NEA 15 Opportunity Fund, L.P.LPs: North Carolina Retirement Systems, California State Teachers' Retirement System2015—25.2%3.68x1.44x
NEA 15, L.P.LPs: North Carolina Retirement Systems2015—11.3%1.83x1.03x
New Enterprise Associates 15LPs: California State Teachers' Retirement System, Sacramento County Employees' Retirement System, Los Angeles City Employees' Retirement System +2 more2015—10.0%1.75x1.05x
NEA 14, L.P.LPs: North Carolina Retirement Systems2012—14.9%2.71x1.14x
New Enterprise Associates 13LPs: California State Teachers' Retirement System, Nebraska Investment Council, New Mexico Public Employees Retirement Association +3 more2008——2.76x2.57x
New Enterprise Associates 12, L.P.LPs: California State Teachers' Retirement System, Washington State Investment Board, Pennsylvania Public School Employees' Retirement System +3 more2006—6.4%1.40x1.39x
New Enterprise Associates 11LPs: California State Teachers' Retirement System, Pennsylvania Public School Employees' Retirement System, Hawaii Employees' Retirement System2004—15.3%2.65x2.57x
New Enterprises Associates VIII A, L.P.LPs: California State Teachers' Retirement System2001—-2.4%0.79x0.79x
New Enterprise Associates 10, L.P.LPs: California State Teachers' Retirement System, Washington State Investment Board, Pennsylvania Public School Employees' Retirement System +2 more2000—2.3%1.20x1.13x
New Enterprise Associates 9, L.P.LPs: California State Teachers' Retirement System, Hawaii Employees' Retirement System, John S. and James L. Knight Foundation1999—-6.1%0.46x0.46x
New Enterprises Associates VIII, L.P.LPs: California State Teachers' Retirement System1998—30.6%1.66x1.64x
NEW ENTERPRISE ASSOCIATES 14, L.P.LPs: California State Teachers' Retirement System, New Mexico Public Employees Retirement Association, Hawaii Employees' Retirement System +3 more———3.31x1.50x

Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).

IPO stake values · per SEC filings · 14

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

CompanyOwnedIPO priceAt IPOStake value
Sprout Social, Inc.14.2%$27.50Aug 2020$166.3M
Monte Rosa Therapeutics15.0%$19.00Jun 2021$126.4M
Spyglass Pharma20.2%$16.00Feb 2026$103.3M
Mirum Pharmaceuticals16.5%$20.00Jan 2020$83.7M
Senseonics Holdings27.4%$2.85Mar 2016$73M
Senseonics27.4%$2.85Mar 2016$73M
Onkure Therapeutics Inc17.0%$15.00Apr 2021$61.8M
Imara21.4%$16.00Mar 2020$56.7M
Enliven Therapeutics21.4%$16.00Mar 2020$56.7M
Black Diamond Therapeutics, Inc7.7%$19.00Jan 2020$50.3M
Trevi Therapeutics27.7%$10.00May 2019$49.3M
Zenas Biopharma3.6%$17.00Sep 2024$24.5M
Synlogic14.8%$7.00Oct 2015$20.8M
Champions Oncology20.9%$2.25Jun 2016$5.4M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

How many investments has New Enterprise Associates (NEA) made?
New Enterprise Associates (NEA) has 1,231 tracked investments, 170 of which have exited, including 99 dated in the last 24 months.
What stage does New Enterprise Associates (NEA) invest at?
New Enterprise Associates (NEA) invests at the Seed, Series A, Series B, Series C, Growth stages.
What is New Enterprise Associates (NEA)'s typical check size?
New Enterprise Associates (NEA) typically writes checks of $200K – $40M.
What sectors does New Enterprise Associates (NEA) focus on?
New Enterprise Associates (NEA) focuses on AI & Machine Learning, Biotech, Consumer, Digital Health, Enterprise Software, Healthtech, Sector Agnostic.
Where is New Enterprise Associates (NEA) located?
New Enterprise Associates (NEA) is headquartered in Menlo Park, US.
Does New Enterprise Associates (NEA) lead rounds?
Yes, New Enterprise Associates (NEA) leads investment rounds.
Who does New Enterprise Associates (NEA) co-invest with?
New Enterprise Associates (NEA) most often shares deals with Andreessen Horowitz, Alumni Ventures, Gaingels, among 1,567 tracked co-investors.

Media · Podcasts & interviews

from their channel

AI for Science : Algorithms to Atoms

NEA VC

Building a Better Future – NEA Companies on a Mission

NEA VC

Optimatik & Forethought:Building Generative AI Companies In a Rapidly Evolving Market

NEA VC

Violet & Everside: Putting Patients First to Transform Care Delivery and Improve Outcomes

NEA VC

Thirteen Lune & Mejuri: Leaning Into Consumer Trends & Cultural Shifts to Build a Powerful D2C Brand

NEA VC

Flowbo & Patreon: Fueling the Creator Economy

NEA VC

Images

New Enterprise Associates (NEA) photo

Co-investors · 404

$100K – $20M
NewView Capital

NewView Capital is a growth-stage investment firm that provides flexible capital to high-potential technology companies, investing on a primary, secondary, or hybrid basis alongside operational support and strategic connections.

▶392 more co-investors

Lightspeed Venture PartnersInsight PartnersMenlo VenturesIndex VenturesBattery VenturesTechstarsBenchmarkBessemer Venture PartnersFelicis VenturesIVP (Institutional Venture Partners)Greylock PartnersNotable CapitalFoundation CapitalFirst Round CapitalSoftBank Vision FundGreycroftLux CapitalSalesforce VenturesSoma CapitalRedpoint VenturesBoxGroupTiger Global ManagementSapphire VenturesLiquid VenturesBond Capital Management8VCOrbiMedSofinnova VenturesCoatue ManagementMadrona Venture GroupF-Prime CapitalIntel CapitalGeneral AtlanticMeritech Capital PartnersRA CapitalAisling CapitalLightstone VenturesBain Capital VenturesCanaan PartnersVenrockLerer HippeauComcast VenturesCisco InvestmentsForesite CapitalEvolution VC PartnersVersant VenturesPfizer Venture InvestmentsMorgenthalerFounders FundCraft VenturesFounder CollectiveGoodwater CapitalCapitalGRuna CapitalUnion Square Ventures (USV)Gradient VenturesThrive CapitalRiverVest Venture PartnersDST GlobalGreat Oaks Venture CapitalRRE VenturesMatrixFlare Capital PartnersSR One Capital ManagementSanofi VenturesVensana CapitalSlow VenturesOak HC/FTSignalFireEmergence Capital PartnersCanvas VenturesTuesday CapitalTenaya CapitalQualcomm VenturesBalderton CapitalSusa VenturesWingSpeedinvestThird Point VenturesStorm VenturesArtis VenturesOUP (Osage University Partners)Roche Venture FundSpark CapitalCRV (Charles River Ventures)Streamlined VenturesACME CapitalInnovation EndeavorsForerunner VenturesFlybridge Capital PartnersMaveronSherpalo VenturesPelion Venture PartnersMaC Venture CapitalICONIQ CapitalARCH Venture PartnersAmerican Express Ventures (Amex)Owl VenturesCollaborative Fund137 VenturesDeerfield Management CompanyAbingworthFrazier Healthcare PartnersNextech InvestPappas CapitalCota CapitalBonfire VenturesAcrew CapitalSierra VenturesRibbit CapitalAtlas VentureNorthzoneDreamers VCAugust CapitalCrosscut VenturesMulticoin CapitalBasis Set VenturesConstruct CapitalRadical VenturesAI FundMVP VenturesAscension VenturesWorkday VenturesBain CapitalClarus VenturesAfore CapitalPear VCWinklevoss CapitalAlleyCorpLakestarEQT Life SciencesLearn Capital5AM VenturesvenBio PartnersGranite AsiaRethink Capital PartnersGreen Bay VenturesTriplePoint CapitalQuadrille CapitalRed & Blue VenturesLong Journey VenturesB Capital GroupEniac VenturesSOSVAME Cloud VenturesKapor CapitalObvious VenturesPICUS CAPITALTrinity VenturesHack VCRidge Ventures01 AdvisorsEQT VenturesCowboy VenturesHV CapitalAIX VenturesDraper Fisher Jurvetson (DFJ)Spider CapitalUnpopular VenturesHOF CapitalGreenoaksEndeavor CatalystGE VenturesAlpaca VCBINARY CAPITALMiramar Venture PartnersThe Column GroupEnergize CapitalYsios CapitalTensility Venture PartnersVelvet Sea VenturesEverywhere VenturesTrue VenturesFirstMark CapitalBling CapitalAccel-KKRAdditionBowery CapitalDCM VenturesHarrison MetalKortschak Investments L.P.Standard CapitalBallistic VenturesWebb Investment NetworkJavelin Venture PartnersBreakthrough Energy VenturesFELIX CAPITALGiant Ventures Global LlpWalden International9Yards CapitalAlvenPitangoModerne VenturesForbionCerity Partners VenturesSlack FundCervinDomain AssociatesNovartis Venture FundGSV VenturesOmega FundsSamsung VenturesUncork CapitalSciFi VCIA VenturesParadigmSocial LeverageAccompliceGlobal Founders CapitalShasta VenturesChemistryThe Chernin Group (TCG Crypto)Next Play VenturesLeft Lane CapitalTransmedia CapitalDecibel PartnersValar Ventures LlcCoelius CapitalFf Venture CapitalFormation GroupMMC VenturesWhite Star CapitalFuture Perfect VenturesScrum VenturesBlueRun VenturesSilverton PartnersEnsemble VCThink+ Ventures Management, LlcRoot Ventures Manager, LlcRace CapitalAmity VenturesSutter Hill VenturesH.I.G. Growth PartnersJAZZ Venture PartnersPaladin Capital GroupTMVPrelude VenturesNorthpond VenturesNeotribe VenturesDimension CapitalJump CapitalIlluminate VenturesCultivation CapitalXplorer CapitalSparkLabs Global VenturesLiveOak VenturesStanford UniversityCavalry VenturesBig Idea VenturesImaginary Venture CapitalElephant PartnersNTT Venture CapitalHarpoon VenturesCVS Health VenturesMercury FundJDRF T1D FundCosmic Venture PartnersQuiet CapitalOffline VenturesFreestyle CapitalHanabi CapitalCostanoa VenturesEclipse VenturesMS&AD VenturesBetaworks Ventures Management, Llc23andMeViola VenturesEnergy Impact PartnersChapter One VenturesOMERS VenturesMosaic VenturesPrefix CapitalPreston-Werner VenturesTeam8StageOne VenturesHelium-3 VenturesJetstreamAmasiaFusionVoyager CapitalHighbury HoldingsAmplo VenturesSignia Venture PartnersPrimitive VenturesMoonfire VenturesWestCapArriveAV8 VenturesAtlantic Bridge VenturesredalpineTola CapitalElaiaMizMaa Ventures7wire VenturesListen VenturesArboretum VenturesOCA VenturesRoosh VenturesArthur VenturesMax VenturesArbor VenturesCore Innovation CapitalOptum VenturesCelonisMorpheus VenturesInkefAnsa CapitalVida VenturesCore Venture Capital17SigmahumbitionAgent CapitalBCF Ventures4BIO CapitalGeekdomLam CapitalOkapi Venture CapitalHBM PartnersSante VenturesM-One CapitalMohr Davidow VenturesSancus VenturesAble PartnersUnknown VenturesUberKrakenGoat CapitalNextView VenturesHCVCStellar CapitalStride VCTrajectory VenturesCatapult CapitalNot Boring CapitalQueensBridge Venture PartnersTq Ventures LlcWGI GroupDigital Currency GroupHyde Park Venture PartnersCompany Capital2xNPolychain CapitalThe Finger GroupProximity VenturesKohlberg Kravis RobertsAllison Pickens Venturesxfactor venturesLa FamigliaK2 GlobalUP PartnersPresight CapitalActive CapitalNext Coast VenturesEuclid Venture PartnersWestWave CapitalFYRFLY Venture PartnersGutbrain VenturesBootstrapLabsS CapitalWalden Catalystf7 VenturesBuilders VCLigature VCMysten LabsRedpoint eventuresMetamorphic VenturesPrime Movers LabPatronMarathon Venture CapitalZintinusAmara VCEnergy Capital VenturesMakers CampMaverick CapitalLeadout CapitalMatter Venture PartnersStarVest PartnersChainforestAmerica's Frontier FundCollide CapitalOpenCapital.vcUpheaval InvestmentsWealthing VC ClubPlaneteer CapitalTuring CapitalVoyager PartnersFlorida FundersOutliers VC82VSEmmeline VenturesNest.Bio VenturesSingle Fin Ventures

Firms observed investing alongside New Enterprise Associates (NEA), from public investor directories. Shared companies are the overlap with New Enterprise Associates (NEA)'s recorded portfolio.

Similar investors

Featured in lists